Time Serial Analysis on Preemptive Analgesia of Preoperative Topical Diclofenac and Ketorolac in Photorefractive Keratectomy(PRK)

NCT01761071 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Myopes Who Have Undergone PRK.

Interventions

DRUG: topical ketorolac 0.5% (Acular®, Allergan Inc, Irvine, CA)
DRUG: topical diclofenac 0.1% (Voltaren®, Novartis, Bern, Switzerland)

Sponsor

Yonsei University